Peptide Advertising: A Platform-by-Platform Policy Guide

Peptides occupy the most hostile corner of health advertising policy. Depending on the compound and the platform, they can be treated as prescription drugs, unapproved substances, or restricted supplements — and each classification triggers different rules, none of them friendly. We've run live peptide campaigns, so this guide is written from scar tissue rather than theory.

Why platforms treat peptides as radioactive

Three overlapping concerns drive enforcement:

1. Regulatory status. Many peptides aren't FDA-approved drugs; several have been explicitly flagged by regulators for compounding restrictions. Platforms track these lists more closely than most advertisers realize.
2. The gray-market association. "Research chemical" sellers pushing peptides for human use poisoned the category — automated filters now treat peptide terminology itself as a risk signal.
3. Health claims. Peptide marketing gravitates toward recovery, longevity, and performance claims that violate misrepresentation policy independent of the substance rules.

The result: even legitimate, physician-supervised peptide therapy inherits suspicion built by the category's worst actors.

Platform by platform

Google — direct peptide-product marketing is largely off the table for non-certified advertisers under prescription and unapproved-substance rules. What's workable: advertising the clinical service — physician-supervised wellness and hormone-optimization care — with certification where prescribing is involved and zero compound names in copy or landing-page claims. The general Google healthcare framework applies at full strength.

Meta — similar posture, compounded by health-data restrictions and automated creative review that catches compound names in ad text, images, and even video captions. Clinic-brand campaigns focused on consultation and provider trust review far more reliably than anything product-led.

Reddit — the most nuanced opportunity. Peptide-curious communities exist and are highly engaged, but Reddit's health ad rules still prohibit unapproved-substance promotion, and community backlash punishes anything that smells like gray-market marketing. Service-led, education-forward creative is the only sustainable path — more in our Reddit guide.

The compliant peptide funnel

What actually stays live, in our experience:

• Advertise the practice, not the compound. The medical service — evaluation, supervision, individualized care — is advertisable in ways no specific peptide is.
• Keep compound education off ad paths. Detailed peptide content can live on your site for SEO and patient education without being the landing page ads point to. Separation matters; platforms review the full path.
• Let organic and AI search carry the specifics. Compound-level questions ("what is BPC-157?") are search and answer-engine queries, not ad inventory. Ranking for them builds the audience your compliant ads then convert.
• Mind the claims everywhere. Recovery and anti-aging promises sink accounts even when the substance rules are technically satisfied.

The pattern mirrors every restricted category we work in: the product may be unadvertisable, but the care rarely is. Providers who internalize that distinction run durable acquisition while the compound-pushers cycle through new ad accounts monthly.

---

Neural Stack has run approved campaigns for peptide and hormone-therapy providers on Google, Meta, and Reddit. Book a free consultation to see what's possible for your practice.